查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1513897

遠端患者監護系統的全球市場

Remote Patient Monitoring Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 442 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球遠端患者監護系統市場預計將達到 91 億美元

2023年全球遠端患者監護系統市場估計為26億美元，預計到2030年將達到91億美元，2023年至2030年複合年成長率為19.6%。專業監視器是本報告分析的細分市場之一，預計複合年成長率為 18.9%，到分析期結束時將達到 72 億美元。分析期間，生命徵象監測儀領域的複合年成長率預計為 22.9%。

美國市場預估價值7.206億美元，中國預期複合年成長率18.6%

到 2023 年，美國遠端患者監護系統市場預計將達到 7.206 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達14億美元，2023-2030年分析期間複合年成長率為18.6%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間複合年成長率分別為 17.0% 和 16.7%。在歐洲，德國的複合年成長率預計約為 13.8%。

全球遠端患者監護系統市場 - 主要趨勢和促進因素總結

遠端患者監護(RPM) 系統在醫療保健領域變得越來越重要，為糖尿病和高血壓等慢性病的管理提供基本服務，並改善護理服務。利用血壓計、血糖值儀等治療設備和智慧型手錶等先進穿戴式設備，RPM 系統可以持續收集健康資料，醫療保健提供者可以使用這些數據來監測患者並相應地調整您的治療計劃。研究強調了 RPM 的好處，包括縮短住院時間以及及時調整治療來改善慢性病的管理。特別是在大流行期間，RPM 已被證明對於遠端監控患者和減輕醫院負擔至關重要。它也被證明在居家醫療計劃中是有效的，透過為家庭患者提供醫院級護理來減少緊急就診和住院治療。

RPM 的監管環境正在迅速發展，特別是受到 COVID-19 大流行期間突出的需求的刺激。隨著醫療保險和醫療補助服務中心 (CMS) 等機構推出新政策和豁免以擴大 RPM 的使用，這些系統變得越來越容易使用，並且適用於各種醫療保健環境。展望未來，先進技術的整合以及對 RPM 優勢的日益認知預示著光明的未來。醫療保健系統擴大採用 RPM 來遠端管理複雜病例，從而減輕實體醫療機構的負擔就證明了這一點。技術的不斷進步和額外的資金增加了 RPM 設備的功能和效率，確保遠端監控仍然是現代醫療保健服務的基本方面。

有幾個因素正在推動 RPM 技術的發展。增強的資料分析和人工智慧整合將提高病患監測的準確性並實現預測性醫療干預。 5G 等改進的連接解決方案將確保從 RPM 設備到醫療保健提供者的可靠資料傳輸。此外，消費者健康意識顯著提高，增加了對提供即時健康指標回饋的健康監測設備的需求。穿戴式科技的普及使持續健康追蹤常態化，進一步提高了 RPM 的接受度。醫療保險和醫療補助等保險公司的支持性法規結構和擴大的報銷政策使 RPM 服務變得更加容易獲得和負擔得起。此外，患者對遠距醫療就診的需求以及醫療保健提供者採用 RPM 來提高業務效率，凸顯了向更整合、技術主導和以患者為中心的醫療保健解決方案的轉變。總的來說，這些因素提高了 RPM 系統的採用率和有效性，並反映了醫療保健管理實踐的持續轉變。

受訪企業範例（共162家）

  • Biotronik SE & Co. KG
  • F. Hoffmann-La Roche AG
  • Intel Corporation
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic of Canada Ltd.
  • Philips Healthcare
  • Robert Bosch GmbH
  • Welch Allyn, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 比賽

簡介目錄
Product Code: MCP-7076

Global Remote Patient Monitoring Systems Market to Reach US$9.1 Billion by 2030

The global market for Remote Patient Monitoring Systems estimated at US$2.6 Billion in the year 2023, is expected to reach US$9.1 Billion by 2030, growing at a CAGR of 19.6% over the analysis period 2023-2030. Special Monitors, one of the segments analyzed in the report, is expected to record a 18.9% CAGR and reach US$7.2 Billion by the end of the analysis period. Growth in the Vital Sign Monitors segment is estimated at 22.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$720.6 Million While China is Forecast to Grow at 18.6% CAGR

The Remote Patient Monitoring Systems market in the U.S. is estimated at US$720.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 18.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.0% and 16.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.8% CAGR.

Global Remote Patient Monitoring Systems Market - Key Trends and Drivers Summarized

Remote Patient Monitoring (RPM) systems are increasingly critical in healthcare, providing vital services for the management of chronic diseases like diabetes and hypertension and enhancing care delivery. Utilizing devices such as blood pressure monitors, blood glucose meters, and advanced wearables like smartwatches, RPM systems allow continuous collection of health data, which healthcare providers use to monitor patients and adjust treatment plans accordingly. Research has highlighted the benefits of RPM, including reducing hospital stay lengths and improving the management of chronic diseases by facilitating timely adjustments in treatment. Especially evident during the pandemic, RPM proved crucial for monitoring patients remotely, alleviating hospital burdens, and has been effective in hospital-at-home programs, which deliver hospital-level care to patients at home, thereby reducing emergency visits and hospitalizations.

The regulatory landscape for RPM has evolved rapidly, particularly spurred by the needs highlighted during the COVID-19 pandemic. Changes by entities like the Centers for Medicare and Medicaid Services (CMS), which introduced new policies and waivers to broaden RPM usage, have made these systems more accessible and applicable across various healthcare settings. Looking forward, the integration of advanced technologies and a growing recognition of the benefits of RPM point to a promising future. This is evidenced by the increasing adoption of RPM by health systems to manage complex cases remotely, thus reducing pressure on physical healthcare facilities. Continued advancements in technology and additional funding are enhancing the capabilities and efficiency of RPM devices, ensuring that remote monitoring remains a foundational aspect of modern healthcare delivery.

Several factors are driving the growth of RPM technology. Enhanced data analytics and AI integration improve patient monitoring accuracy, enabling predictive healthcare interventions. Improvements in connectivity solutions, such as 5G, ensure reliable data transmission from RPM devices to healthcare providers. There's also a significant increase in consumer health awareness, which has boosted demand for health monitoring devices providing real-time health metrics feedback. The popularity of wearable technologies has normalized continuous health tracking, further aiding RPM acceptance. Supportive regulatory frameworks and expanded reimbursement policies by insurance providers, including Medicare and Medicaid, are making RPM services more accessible and affordable. Additionally, patient demand for remote care options and healthcare providers' adoption of RPM for operational efficiency highlight the shift towards more integrated, technology-driven, and patient-centered healthcare solutions. These factors collectively enhance the adoption and effectiveness of RPM systems, reflecting an ongoing transformation in healthcare management practices.

Select Competitors (Total 162 Featured) -

  • Biotronik SE & Co. KG
  • F. Hoffmann-La Roche AG
  • Intel Corporation
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic of Canada Ltd.
  • Philips Healthcare
  • Robert Bosch GmbH
  • Welch Allyn, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Remote Patient Monitoring Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Telehealth and Remote Healthcare Solutions
    • Growth of the Aging Population and Chronic Disease Management
    • Advancements in Remote Monitoring Technologies and Wearable Devices
    • Rising Adoption of Remote Patient Monitoring in Post-Acute Care
    • Impact of COVID-19 Pandemic on Healthcare Delivery and Remote Monitoring
    • Government Regulations and Standards for Telehealth and Remote Monitoring
    • Expansion of Remote Monitoring Applications in Home Healthcare
    • Development of Integrated and Real-Time Health Monitoring Platforms
    • Role of Remote Monitoring in Enhancing Patient Outcomes and Healthcare Efficiency
    • Market Penetration of Remote Monitoring in Rural and Underserved Areas
    • Influence of Technological Innovations on Data Accuracy and Connectivity
    • Growth of Remote Monitoring Applications in Chronic Disease Management
    • Challenges Related to Data Security and Patient Privacy Concerns
    • Emerging Markets and Growth Opportunities in Developing Regions
    • Future Trends and Innovations in Remote Patient Monitoring Systems and Healthcare Delivery
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Vital Sign Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Vital Sign Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Vital Sign Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Special Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Special Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Special Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Sleep Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Sleep Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Sleep Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hospital based Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Hospital based Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Hospital based Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Ambulatory Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Ambulatory Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Ambulatory Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Hypertension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Hypertension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Hypertension by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 34: World Remote Patient Monitoring Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Remote Patient Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Remote Patient Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • JAPAN
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • CHINA
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • EUROPE
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Remote Patient Monitoring Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Remote Patient Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • GERMANY
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030

IV. COMPETITION